Bioeconomy initiative

Accelerating the global transition to a bio-based economy

The time is now for biosolutions. Industries are recognizing the breakthrough potential of engineering biology techniques, which harness the power of natural biological processes to address critical planetary challenges. These innovations are essential for a healthy, prosperous, and sustainable future. They allow us to reimagine supply chains and economies globally, reshaping industries at every level. However, despite their revolutionary potential, biosolutions are rarely reaching the commercial mainstream.

As a strategic partner of the World Economic Forum, Capgemini has been co-leading the Forum’s Bioeconomy Initiative. This initiative has built a multi-stakeholder community to foster dialogue and collaboration across industries, sectors, and economies, driving forward innovation and unlocking value.

Latest reports

Next generation bio-innovation: Delivering commercial value

Biology is poised to drive commercial value. A shift towards differentiated value creation can transform the bioeconomy.

This latest paper from the World Economic Forum in collaboration with Capgemini dives into how biology can revolutionize industries and drive commercial success.

Download the brochure here

From policy to practice: Actionable recommendations for a commercial bioeconomy

Global trade disruptions and sustainability pressures are accelerating the need for resilient, bio-based industries. While more than 50 national bioeconomy strategy frameworks have emerged worldwide, many remain visionary, lacking the concrete implementation plans needed to drive real-world impact.

This report uncovers a critical disconnect: technological innovation is advancing rapidly, yet commercialization continues to lag.

Download on the Forum’s website

Accelerating the tech-driven bioeconomy

The time is ripe for a global transition to a bio-based economy. Powered by the ever-evolving capacity to read, write, edit and increasingly functionalize deoxyribonucleic acid (DNA), the tech-enabled bioeconomy promises fundamental improvements in everyday life.

Digital advances are also expanding the areas where biology can deliver impact, and generative biology is set to disrupt several industries. Yet, despite decades of investment and technological progress, as well as sanguine market projections, the global transition to a bio-based economy has yet to enter the commercial mainstream.

Download on the Forum’s website